A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myelom…

Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more

~Estimated

~$10 – $8,750

CellCentric Ltd.NCT04068597

Phase 2

Randomized Clinical Trial to Evaluate the Use of Genotype-based Dosing of Voriconazole

This project aims to address invasive fungal infections in patients, by precision dosing of voriconazole based on CYP2C19 genotype testing with Bayesian dose-f…

Fungal InfectionHaematological MalignancyBlood Cancer+1 more

~Estimated

~$10 – $6,250

The University of QueenslandNCT06510699